Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Hepatic Dysfunction, Vitamin D Status, and Glycemic Control in Diabetes [Phase 3]
Phase 3 trial evaluating hepatic dysfunction and vitamin D status in people with type 2 diabetes mellitus and nonalcoholic fatty liver disea…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Understanding the Role of Dietary Fatty Acids on Liver Fat Metabolism in Humans [NA]
The University of Oxford completed a clinical trial to understand how dietary fatty acids influence liver fat metabolism in humans, in the c…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH) [Phase 2]
This update reports Phase 2 trial results for recombinant leptin therapy in nonalcoholic steatohepatitis (NASH).
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease
A completed clinical trial evaluated the impact of bariatric surgery on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Effect of resVida on Liver Fat Content [NA]
This completed clinical trial assessed whether resVida reduces liver fat content in individuals with elevated liver fat and insulin resistan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease [NA]
A completed clinical trial comparing exercise versus dietary modification for the treatment of nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease [Phase 4]
A Phase 4 trial evaluated whether adding exenatide to insulin therapy improves outcomes in adults with type 2 diabetes and nonalcoholic fatt…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases [Phase 2]
Completed Phase 2 clinical trial of Emricasan (IDN-6556) in subjects with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;…
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids in Menopausal Women [NA]
This clinical trial update reports a study evaluating a lacto-ovo-vegetarian diet enriched with omega-3 fatty acids in menopausal women, wit…
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
A completed case-control clinical trial evaluating how common nonalcoholic fatty liver disease is among patients with psoriasis.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes [Phase 3]
Phase 3 trial evaluating rimonabant for nonalcoholic steatohepatitis in patients with type 2 diabetes was terminated; no final efficacy resu…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Role of Exenatide in NASH-a Pilot Study [Phase 2, Phase 3]
Clinical trial update showing a pilot Phase 2/3 study of exenatide in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Res…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients [Phase 4]
A Phase 4 trial evaluating the impact of liraglutide on cardiovascular endpoints in adults with type 2 diabetes; the study status is complet…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the effects of a flaxseed supplement on biochemical factors and hepatic fibrosis in patients with nona…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group [Phase 3]
A Phase 3 study evaluated different doses of S-adenosyl-L-methionine (SAMe) in individuals with nonalcoholic fatty liver disease, with resul…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis [Phase 3]
Phase 3 trial in children with nonalcoholic steatohepatitis evaluating the efficacy and tolerability of DHA, choline, and vitamin E has comp…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.) [NA]
This update reports the completion of a trial evaluating endoscopic ultrasound-guided TRUCUT biopsy for suspected nonalcoholic fatty liver d…
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Elevated Circulating FFA and Intrahepatic Lipid Content [NA]
A clinical trial investigating elevated circulating free fatty acids and intrahepatic lipid content in people with diabetes and hepatic stea…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism [Phase 4]
Phase 4 MRI substudy examining metabolic changes related to iatrogenic hypogonadism in patients with prostate cancer and metabolic syndrome;…
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT) [Phase 2]
Phase 2 FLINT trial of obeticholic acid for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis reported results, showing hist…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT) [Phase 2]
Phase 2 study evaluating a 13C octanoate breath test to predict liver disease severity in metabolic syndrome and nonalcoholic fatty liver di…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH) [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating omega-3 fish oil supplements versus placebo in patients with nonalcoholic steatohepatitis an…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 4]
A Phase 4 clinical trial update on metformin for nonalcoholic fatty liver disease (NAFLD) shows the study was terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Combined Intensive and Conventional Exercise on Nonalcoholic Fatty Liver Disease (NAFLD) [Phase 3]
A Phase 3 clinical trial assessing combined intensive and conventional exercise for nonalcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes [Phase 2]
Phase 2 trial comparing liraglutide to insulin in patients with type 2 diabetes to assess liver fat fraction in nonalcoholic fatty liver dis…